Bufferin Low Dose Interactions
There are 370 drugs known to interact with Bufferin Low Dose (aspirin), along with 9 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 61 are major, 267 are moderate, and 42 are minor.
- View all 370 medications that may interact with Bufferin Low Dose
- View Bufferin Low Dose alcohol/food interactions (2)
- View Bufferin Low Dose disease interactions (9)
Most frequently checked interactions
View interaction reports for Bufferin Low Dose (aspirin) and the medicines listed below.
- amlodipine
- amlodipine
- atorvastatin
- atorvastatin
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- gabapentin
- hydrochlorothiazide
- hydrochlorothiazide
- levothyroxine
- levothyroxine
- lisinopril
- lisinopril
- losartan
- losartan
- metformin
- metformin
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Succinate ER (metoprolol)
- omeprazole
- omeprazole
- rosuvastatin
- rosuvastatin
- turmeric
- turmeric
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
Bufferin Low Dose alcohol/food interactions
There are 2 alcohol/food interactions with Bufferin Low Dose (aspirin).
Bufferin Low Dose disease interactions
There are 9 disease interactions with Bufferin Low Dose (aspirin) which include:
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
Report options
QR code containing a link to this page
More about Bufferin Low Dose (aspirin)
- Compare alternatives
- Reviews (1)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: platelet aggregation inhibitors
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
